Trade JnJ ^JNJ

3 Dividend Stocks That Are No-Brainer Buys for the Second Half of 2026

Best Pharmaceutical Stocks To Follow Today - August 2nd - Markets Daily

Keel Point LLC Sells 7,019 Shares of Johnson & Johnson $JNJ

Financial Solutions Advisory Group Inc. Makes New $607,000 Investment in Johnson & Johnson $JNJ

Edgestream Partners L.P. Lowers Stock Position in Johnson & Johnson $JNJ - Daily Political

First Nebraska Trust Co Makes New Investment in Johnson & Johnson $JNJ - Daily Political

3 Dividend Stocks to Buy and Hold Forever

Johnson & Johnson (JNJ) Stock Sees Modest Fair Value Lift After Analyst Target Increases

Your Employer Might Pay You to Exercise. Here's Why. - AOL

Argent Capital Management LLC Sells 9,412 Shares of Johnson & Johnson $JNJ

Johnson & Johnson (NYSE:JNJ) Downgraded to Hold Rating by Wall Street Zen

Johnson & Johnson $JNJ Shares Sold by Compass Capital Management Inc. - Daily Political

Top Healthcare Stocks To Watch Today - July 30th - Daily Political

Abbott Laboratories vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

Johnson & Johnson vs. Danaher: Which Healthcare Stock Looks Better Positioned Following Earnings?

XLV vs. IHE: Which Healthcare ETF Is the Better Buy?

Best Medical Stocks To Follow Now - July 31st - Stock Observer

Is Wall Street Bullish or Bearish on Johnson & Johnson Stock?

Top Healthcare Stocks To Research - July 31st - Stock Observer

Johnson & Johnson embarks on supply chain restructuring

Recent Analysts' Ratings Changes for Johnson & Johnson (JNJ) - Markets Daily

JNJ: New Drug Cycle And Talc Settlement Progress Will Balance Policy Risks

Johnson & Johnson $JNJ Shares Bought by Western Wealth Management LLC - Daily Political

Johnson & Johnson (NYSE:JNJ) Stock Price Down 3.6% - Time to Sell?

Johnson & Johnson Just Got FDA Clearance for Its Surgical Robot, Hiked Its Dividend for the 64th Time, and Is Targeting $100 Billion in Revenue. But Here's What Investors Should Be Most Excited About

Decongestant class action sputters back to life in Second Circuit

Hamilton Wealth LLC Buys 2,542 Shares of Johnson & Johnson $JNJ - Zolmax

Janus Henderson Group PLC Has $1.92 Billion Position in Johnson & Johnson $JNJ - Zolmax

Best Healthcare Stocks To Keep An Eye On - July 29th - Stock Observer

South Dakota Investment Council Lowers Position in Johnson & Johnson $JNJ - Markets Daily

Johnson & Johnson $JNJ is Tri Locum Partners LP's Largest Position

Johnson & Johnson $JNJ Shares Sold by Stempoint Capital LP

Tri Locum Partners LP Sells 188,640 Shares of Johnson & Johnson $JNJ - Stock Observer

Bank of America Corp DE Trims Stock Holdings in Johnson & Johnson $JNJ

J&J Strikes $3.51 Bln Deal With Sail To Develop In-Vivo CAR-T Therapies For Immune Diseases

Johnson & Johnson $JNJ Shares Acquired by Hamilton Wealth LLC - Daily Political

Johnson & Johnson seeks to end decade-long talc litigation with $5.5 billion settlement - The Economic Times

Johnson & Johnson (JNJ) Seeks $5.5 Billion Talc Lawsuit Settlement

Johnson & Johnson Comes to Strategic Agreement with Sail Biomedicines | Morningstar

Trump questions the validity of Fauci pardon due alleged use of autopen by Biden | Watch News Videos Online

Trump vows to hit Iran 'very hard' after Iranian attack on US base in Jordan | Watch News Videos Online

Sail Biomedicines Announces Strategic Collaboration to Develop New Class of Medicines for In Vivo CAR-T

Meet the Stock That's Obliterating Eli Lilly, Johnson & Johnson, and AbbVie Right Now

Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation | INN

Johnson & Johnson agrees to pay billions in cancer lawsuit settlement - AOL

Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset | INN

Explainer-Can J&J finally put the talc litigation behind it? - AOL

Agentic AI startup Freehand closes $75 million funding

Johnson & Johnson baby powder causing cancer? What is behind the $5.5 billion settlement

Johnson & Johnson Announces $5.5 Billion Settlement of Talc Lawsuits

Johnson & Johnson vs. Eli Lilly: Reliable Stability vs. Rapid Revenue Growth

Smith Group Asset Management LLC Acquires 11,139 Shares of Johnson & Johnson $JNJ - Zolmax

Best Medical Stocks Worth Watching - July 28th

Johnson & Johnson baby powder controversy: Does your baby really need talcum powder? - India Today

EverSource Wealth Advisors LLC Boosts Holdings in Johnson & Johnson $JNJ

Why Johnson & Johnson agreed to pay $5.5 billion despite denying cancer claims

Arete Wealth Advisors LLC Acquires 11,789 Shares of Johnson & Johnson $JNJ

Amundi Has $3.28 Billion Stock Holdings in Johnson & Johnson $JNJ

J&J's $5.5 billion talc settlement: Look at biggest corporate payouts in history

EverSource Wealth Advisors LLC Raises Holdings in Johnson & Johnson $JNJ - Stock Observer

Smith Group Asset Management LLC Has $36.70 Million Holdings in Johnson & Johnson $JNJ - Daily Political

Johnson & Johnson (NYSE:JNJ) EVP Vanessa Broadhurst Sells 23,054 Shares of Stock - Daily Political

J&J seals deal to end a decade of cancer litigation

Mint Quick Edit | Johnson & Johnson's $5.5 billion offer to settle cancer-risk suits: is money enough? | Mint

How a 44-Year-Old Could Build a $9,000 Monthly Paycheck by 60 Without Maxing a 401(k)

De-escalation trials in multiple myeloma: past, present and future

What Johnson & Johnson Stock Told You Before It Surged

Johnson & Johnson (JNJ) Stock: Surges as J&J Offers $5.5 Billion Talc Settlement to End Cancer Lawsuits

Johnson & Johnson (JNJ) Stock May Be 31% Undervalued As Myeloma Trial Results Impress

Johnson & Johnson To Settle Baby Powder Lawsuit Over A Decade Later - AOL

Johnson & Johnson agrees to $5.5B settlement over talc cancer claims | Fox Business

Johnson & Johnson (NYSE:JNJ) EVP Vanessa Broadhurst Sells 23,054 Shares - Markets Daily

Johnson & Johnson proposes $5.5B settlement to resolve remaining talc litigation

Johnson & Johnson offers up to $5.5 billion to settle baby powder cancer lawsuits

J&J reaches sweeping talc deal that could end decade of litigation

Johnson & Johnson Offers $5.5bn Talc Settlement: Who Could Qua...

Johnson & Johnson agrees to USD 5.5 billion settlement in talc litigation case

Johnson & Johnson settling talc baby powder lawsuits for $5.5 billion

Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fight - AOL

Johnson & Johnson creates $5.5B fund to settle baby powder lawsuits

Is talcum powder safe?

Vanessa Broadhurst Sells 23,054 Shares of Johnson & Johnson (NYSE:JNJ) Stock - Stock Observer

Johnson & Johnson (NYSE:JNJ) Sets New 1-Year High - Here's What Happened - Stock Observer

Johnson & Johnson's $5.5 billion talc lawsuit settlement: Here's what the deal covers

Johnson & Johnson $JNJ Shares Acquired by Evelyn Partners Investment Management Services Ltd

Johnson & Johnson $JNJ Shares Sold by Evercore Wealth Management LLC

Johnson & Johnson to pay nearly ₹52,700 crore after lawsuits linked baby powder to ovarian cancer | Company Business News

Johnson & Johnson offers £4.1bn to settle talcum powder cancer claims

Healthcare Stocks To Keep An Eye On - July 28th - Daily Political

Johnson & Johnson hasagreed to pay $5.5 billion over talc claims. Here's how the legal battle finally ended

ServiceNow Stock Forecast 2026: Is NOW Undervalued After the Sell-Off?

Intel Stock Forecast 2026–2030: What Could Drive INTC?

USD to INR Forecast 2026, 2030 & Beyond: Will the Rupee Weaken Further?

USD to CAD Forecast 2026: Will USD/CAD Hold Above 1.40?

Apple Stock Forecast 2026, 2027 and 2030: Key AAPL Drivers

Meta Platforms Inc Stock (META) Forecast 2030: Is $1,000 Possible?

Microsoft Stock Forecast 2026–2030: What Could Drive MSFT?

AUD to USD Forecast 2026: Can the Australian Dollar Reach US$0.72?

GBP to USD Forecast 2026: Will the British Pound Rise or Fall Against the US Dollar?

SNDK Stock Forecast 2026–2030: Can SanDisk Keep Rising?

Gold Price Today, August 3: XAU/USD Rebounds Above $4,050

Yen Surges Over 1% After Coordinated US-Japan Intervention

Caterpillar Stock Edges Higher Ahead of Q2 Earnings as Data Center Demand Faces Key Test

Oil Prices Tumble Up to 8% as U.S.-Iran Diplomacy Returns

AMD Earnings Date Confirmed as Options Market Signals a Potential 12% Stock Move

Palantir Q2 Earnings Preview: U.S. Commercial Growth and Guidance in Focus

AI Storage Boom Faces Its Next Test as Sandisk Earnings Date Nears

US Stocks Face Jobs Data and a Blockbuster Earnings Week as SpaceX Makes Its Post-IPO Debut